GFR vs NOG

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

GFR

34.7
AI Score
VS
NOG Wins

NOG

51.7
AI Score

Investment Advisor Scores

GFR

35score
Recommendation
AVOID NEW MONEY

NOG

52score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric GFR NOG Winner
Forward P/E 8.4104 4.4703 NOG
PEG Ratio 0 7.3495 Tie
Revenue Growth 21.9% 43.7% NOG
Earnings Growth -38.2% 119.0% NOG
Tradestie Score 34.7/100 51.7/100 NOG
Profit Margin -6.3% -21.2% GFR
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY STRONG BUY NOG

Relative Price Performance (Last 90 Days)

GFR 1M: +21.1% · 3M: +8.2% NOG 1M: -7.9% · 3M: -2.8%

Current Technical Phase

GFR

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.5% over 20 days), RSI 65

RSI (14): 64.8 · Price: $7.68

NOG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 40

RSI (14): 39.5 · Price: $23.41

Fundamentals Snapshot

Metric GFR NOG
Market Cap — —
Forward P/E 9.6 4.5
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.2% 0.4%
Gross Margin 0.3% 0.8%
Operating Margin 0.4% -0.1%
EPS -0.27 -4.58
Dividend Yield — 0.08%

Frequently Asked Questions

Based on our detailed analysis, NOG is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.